MDCG2020-10∕1修订版1 《欧盟法规(EU)2017745》下医疗器械临床研究中的安全性报告
MDCG 2020-10/1 1
EU2017/745
2022 10
2017/745 103 MDCGMDCG
Page 1 of 19
5.1
9.4
5.2.2
10.2.1
4
5
10.2.19 - 20
10.2.15 17
MDCG 2020-10/1 1
Page 2 of 19
May 2020
MDCG 2020-10 Rev 1
Safety reporting in clinical investigations
of medical devices under the Regulation (EU) 2017/745
1 ............................................................................................................................................................................................................................................................................................................ 3
1.1 EUDAMED ...................................................................................................................................................................................................................................................................3
2 ............................................................................................................................................................................................................................................................................................................ 4
2.1 ............................................................................................................................................................................................................................................................................................................4
2.2 ..................................................................................................................................................................................................................................................................4
3 ............................................................................................................................................................................................................................................................................................................ 5
3.1 ........................................................................................................................................................................................................................................................................................5
3.2 AE ............................................................................................................................................................................................................................................................................ 5
3.3 SAE .................................................................................................................................................................................................................................................................. 5
3.4 ............................................................................................................................................................................................................................................................................................5
4 ..................................................................................................................................................................................................................................................................................................... 6
4.1 EUDAMED .............................................................................................................................................................................................................................................................................6
4.2 NCAS ......................................................................................................................................................................................................................................................................6
4.3 ........................................................................................................................................................................................................................................................................................................6
5 ............................................................................................................................................................................................................................................................................................... 7
5.1 74.1 PMCF ............................................................................................................................................................................................................7
5.2 .............................................................................................................................................................................................................................................................7
5.3 ..........................................................................................................................................................................................................................................7
5.4 PMCF ......................................................................................................................................................................................................................................8
6 ........................................................................................................................................................................................................................................................................................ 8
7 .................................................................................................................................................................................................................................................................................................... 8
8 ............................................................................................................................................................................................................................................................................................... 8
8.1 NCAS .............................................................................................................................................................................................................................................................................................8
8.2 ................................................................................................................................................................................................................................................................................................9
9 ............................................................................................................................................................................................................................................................................................ 9
10 .................................................................................................................................................................................................................................................................................................. 11
10.1 ................................................................................................................................................................................................................................................................................11
10.2 ........................................................................................................................................................................................................................................................................13
11 .................................................................................................................................................................................................................................................................................................. 16
12 ...................................................................................................................................................................................................................................................... 16
Page 3 of 19
摘要：
展开>>
收起<<
MDCG2020101OrH10kvlEU20177450NSuVhhN4xzvNvQhbTJ2022t10ggeNu1kv2017745Sl103gazvSuVhhSOMDCGS0MDCGu1bgbTXVvNhbu1kvYTXOvNTNhbNN0eNvkm2YTXOeNNNSfkm2YTXOvezW0geNNhvNOUpWGNQwglgRSgkm2TvlbYkvlOQQwggRv0Page1of19evxNR5194onon522102145hhQS10219201021517eNIMDCG2020101OrH1vSfQsNbTJLvfQsNXkQbTJhvffePage2of19May20...
声明：如果您的权利被侵害，请联系我们的进行举报。
相关推荐
-
ISO 14155-2020 医疗器械临床实验管理规范（中文版）VIP免费
2025-09-17 314 -
ISO TS 10974-2018 评估有植入式医疗设备的患者进行磁共振成像的安全性VIP免费
2025-10-30 165 -
ISO TS 10974-2018 评估有植入式医疗设备的患者进行磁共振成像的安全性（中文版）
2025-10-30 172 -
ISO TS 10974-2018 评估有植入式医疗设备的患者进行磁共振成像的安全性_中英文版VIP专享
2025-10-30 104 -
ISO 10993-1-2018 医疗器械生物学评价 第1部分：风险管理过程中的评价与试验_中英文对照VIP专享
2025-11-03 123 -
ISO 14155-2026 人体医疗器械临床试验--良好临床实践VIP免费
2026-04-15 114 -
ISO IEC 17020 2026 Conformity assessment— Requirements for bodies performing inspectionVIP免费
2026-05-14 104 -
ISO 19011-2026-管理体系审核指南VIP免费
2026-06-03 90 -
ISO 19011-2026-管理体系审核指南（中文）VIP免费
2026-06-04 179 -
ISO FDIS 9001_2026质量管理体系要求中英文版VIP免费
2026-07-02 123
作者：一如既往
分类：法规规范
价格：100质量币
属性：19 页
大小：3.03MB
格式：PDF
时间：2026-03-17
